---
layout: minimal-medicine
title: Landiolol
---

# Landiolol
### Generic Name
Landiolol

### Usage
Landiolol is a short-acting beta-blocker primarily used for the rapid control of heart rate in specific situations. Its main uses include managing supraventricular tachycardia (rapid heartbeat originating above the ventricles), and controlling a fast ventricular rate in patients with atrial fibrillation or atrial flutter.  These conditions often arise during or after surgery (perioperative/postoperative) or in other circumstances where short-term heart rate control is needed. It's also indicated for non-compensatory sinus tachycardia (a fast heart rate that isn't a compensatory response to another condition) requiring intervention.  It's crucial to remember that Landiolol is not for long-term use.

### Dosage
Landiolol is administered intravenously (IV). Dosage varies depending on the patient's condition and response.

**Adults:** For intra- and postoperative cardiac arrhythmias, a typical regimen involves a loading dose of 0.1 mg/kg given over one minute, followed by a continuous infusion of 0.04 mg/kg/min.  If rapid onset isn't critical, the infusion can start at a lower maintenance rate of 0.01-0.04 mg/kg/min. The maximum daily dose is 0.08 mg/kg/min. Dosage adjustments may be necessary for patients with impaired left ventricular function, requiring lower starting doses and careful blood pressure monitoring.  Transitioning to another medication (oral antiarrhythmics) should be done gradually under close supervision; Landiolol should be reduced by 50% after the first dose of the alternative drug and discontinued once adequate control is maintained for at least an hour after the second dose.

**Children:** The safety and effectiveness of Landiolol in children under 18 years old haven't been established.

**Dosage Adjustments:**  Lower starting doses are recommended for patients with hepatic (liver) impairment. Renal (kidney) impairment usually doesn't require dosage changes but warrants cautious use.


### Side Effects
Common side effects can include:

* Bradycardia (slow heart rate)
* Hypotension (low blood pressure)
* Headache
* Nausea

Less common, but potentially serious side effects, include:

* Cardiac arrest
* Myocardial infarction (heart attack)
* Stroke
* Allergic reactions

If any adverse effects occur, consult a healthcare professional immediately.

### How it Works
Landiolol is a highly selective beta-1 adrenoreceptor antagonist. This means it primarily blocks beta-1 receptors found in the heart.  By blocking these receptors, Landiolol reduces the effects of adrenaline and noradrenaline on the heart, thus slowing down the heart rate. It decreases the sympathetic drive (the body's "fight-or-flight" response) which leads to a reduced heart rate, slower conduction through the heart's electrical system, and longer intervals between heartbeats. Importantly, it lacks intrinsic sympathomimetic activity (doesn't stimulate the heart) and membrane-stabilizing effects (doesn't affect the heart muscle's electrical properties in the same way as some other beta-blockers).

### Precautions
Landiolol is contraindicated (should not be used) in patients with:

* Allergy to Landiolol
* Cardiogenic shock
* Second- or third-degree atrioventricular (AV) block
* Severe sinus bradycardia
* Sick sinus syndrome
* Severe AV nodal conduction disorders (without a pacemaker)
* Severe hypotension
* Decompensated heart failure (unrelated to the arrhythmia)
* Pulmonary hypertension
* Untreated pheochromocytoma
* Acute asthmatic attack
* Severe uncorrectable metabolic acidosis

Use with caution in patients with:

* Bronchospastic disease
* Hyperthyroidism
* History of severe anaphylaxis
* Diabetes mellitus
* Peripheral vascular disease
* Renal or hepatic impairment
* First-degree heart block
* Pre-existing heart failure
* Patients receiving anesthesia or undergoing surgery
* Hemodynamically compromised patients or those taking other drugs affecting peripheral resistance, myocardial filling, contractility, or electrical impulse propagation.

Concomitant administration with verapamil or diltiazem is not recommended in patients with atrioventricular conduction abnormalities.  Landiolol should be used cautiously and only after pre-treatment with alpha-receptor blockers in patients with pheochromocytoma.

Pregnancy and Lactation:  Avoid use during pregnancy unless strictly necessary, with close monitoring of the mother and fetus.  Excretion in breast milk is unknown; a decision must be made about breastfeeding versus treatment based on individual risk assessment.


### FAQs

* **Q: How long does Landiolol take to work?** A: The onset of action varies. With a loading dose, effects are usually seen within 2-4 minutes.  Starting with a lower maintenance dose might take 10-20 minutes.

* **Q: How is Landiolol administered?** A: It's always given intravenously (IV) by a healthcare professional in a monitored setting.

* **Q: Can I stop taking Landiolol suddenly?** A: No.  Always discontinue Landiolol gradually under medical supervision to prevent potential complications.

* **Q: Can I take Landiolol with other medications?** A:  Inform your doctor about all medications you're taking, including over-the-counter drugs and herbal supplements.  Interactions with other medications are possible, particularly those affecting heart function or blood pressure.

* **Q: How should I store Landiolol?** A:  Follow the specific storage instructions provided by your pharmacist or on the medication label.  Reconstituted Landiolol should be used immediately.


**Disclaimer:** This information is for educational purposes only and should not be considered medical advice.  Always consult with a healthcare professional before starting or changing any medication.
